BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29698447)

  • 1. Celecoxib use and circulating oxylipins in a colon polyp prevention trial.
    Martinez JA; Yang J; Wertheim BC; Roe DJ; Schriewer A; Lance P; Alberts DS; Hammock BD; Thompson PA
    PLoS One; 2018; 13(4):e0196398. PubMed ID: 29698447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
    N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Protective Role for Arachidonic Acid Metabolites against Advanced Colorectal Adenoma in a Phase III Trial of Selenium.
    Martinez JA; Skiba MB; Chow HS; Chew WM; Saboda K; Lance P; Ellis NA; Jacobs ET
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G; Lynch PM; Phillips RK; Wallace MH; Hawk E; Gordon GB; Wakabayashi N; Saunders B; Shen Y; Fujimura T; Su LK; Levin B; Godio L; Patterson S; Rodriguez-Bigas MA; Jester SL; King KL; Schumacher M; Abbruzzese J; DuBois RN; Hittelman WN; Zimmerman S; Sherman JW; Kelloff G
    N Engl J Med; 2000 Jun; 342(26):1946-52. PubMed ID: 10874062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting.
    Schmöcker C; Zhang IW; Kiesler S; Kassner U; Ostermann AI; Steinhagen-Thiessen E; Schebb NH; Weylandt KH
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of Drug Concentration at the Site of Action: Celecoxib and Colon Polyp Prevention as a Case Study.
    Thompson PA; Martinez JA
    Cancer Prev Res (Phila); 2022 Apr; 15(4):205-208. PubMed ID: 35373257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.
    Chan FKL; Ching JYL; Tse YK; Lam K; Wong GLH; Ng SC; Lee V; Au KWL; Cheong PK; Suen BY; Chan H; Kee KM; Lo A; Wong VWS; Wu JCY; Kyaw MH
    Lancet; 2017 Jun; 389(10087):2375-2382. PubMed ID: 28410791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
    Davies JR; Mell T; Fuller H; Harland M; Saleh RNM; Race AD; Rees CJ; Brown LC; Loadman PM; Downing A; Minihane AM; Williams EA; Hull MA
    Cancer Prev Res (Phila); 2023 Nov; 16(11):621-629. PubMed ID: 37756582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation.
    Berthelot CC; Kamita SG; Sacchi R; Yang J; Nording ML; Georgi K; Hegedus Karbowski C; German JB; Weiss RH; Hogg RJ; Hammock BD; Zivkovic AM
    PLoS One; 2015; 10(12):e0144996. PubMed ID: 26672987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspective on the cardiovascular effects of coxibs.
    Konstam MA; Weir MR
    Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial.
    Gordo AC; Walker C; Armada B; Zhou D
    J Int Med Res; 2017 Feb; 45(1):59-74. PubMed ID: 28222627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors.
    White WB; Kent J; Taylor A; Verburg KM; Lefkowith JB; Whelton A
    Hypertension; 2002 Apr; 39(4):929-34. PubMed ID: 11967252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Body PET Imaging in Humans Shows That
    Kim MJ; Anaya FJ; Manly LS; Lee JH; Hong J; Shrestha S; Telu S; Henry K; Santamaria JAM; Liow JS; Zanotti-Fregonara P; Shetty HU; Zoghbi SS; Pike VW; Innis RB
    J Nucl Med; 2023 Jan; 64(1):159-164. PubMed ID: 35798558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate intake attenuates post-exercise plasma levels of cytochrome P450-generated oxylipins.
    Nieman DC; Gillitt ND; Chen GY; Zhang Q; Sakaguchi CA; Stephan EH
    PLoS One; 2019; 14(3):e0213676. PubMed ID: 30883596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
    Gyllfors P; Bochenek G; Overholt J; Drupka D; Kumlin M; Sheller J; Nizankowska E; Isakson PC; Mejza F; Lefkowith JB; Dahlén SE; Szczeklik A; Murray JJ; Dahlén B
    J Allergy Clin Immunol; 2003 May; 111(5):1116-21. PubMed ID: 12743579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib for the prevention of sporadic colorectal adenomas.
    Bertagnolli MM; Eagle CJ; Zauber AG; Redston M; Solomon SD; Kim K; Tang J; Rosenstein RB; Wittes J; Corle D; Hess TM; Woloj GM; Boisserie F; Anderson WF; Viner JL; Bagheri D; Burn J; Chung DC; Dewar T; Foley TR; Hoffman N; Macrae F; Pruitt RE; Saltzman JR; Salzberg B; Sylwestrowicz T; Gordon GB; Hawk ET;
    N Engl J Med; 2006 Aug; 355(9):873-84. PubMed ID: 16943400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in bioactive lipid mediators in response to short-term exposure to ambient air particulate matter: A targeted lipidomic analysis of oxylipin signaling pathways.
    Wang T; Han Y; Li H; Wang Y; Xue T; Chen X; Chen W; Fan Y; Qiu X; Gong J; Xu Y; Wang J; Li W; Zhu T
    Environ Int; 2021 Feb; 147():106314. PubMed ID: 33326904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
    Simon LS; Weaver AL; Graham DY; Kivitz AJ; Lipsky PE; Hubbard RC; Isakson PC; Verburg KM; Yu SS; Zhao WW; Geis GS
    JAMA; 1999 Nov; 282(20):1921-8. PubMed ID: 10580457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal exposure to consumer product chemicals and changes in plasma oxylipins in pregnant women.
    Welch BM; Keil AP; Bommarito PA; van T' Erve TJ; Deterding LJ; Williams JG; Lih FB; Cantonwine DE; McElrath TF; Ferguson KK
    Environ Int; 2021 Dec; 157():106787. PubMed ID: 34314981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.